Works Cited

1. Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health-Syst Pharm. 2002;59(11):1067-1076.

2. Britt GC, McCance-Katz EF. A brief overview of the clinical pharmacology of "club drugs." Subst Use Misuse. 2005;40(9-10):1189-1201.

3. Rimsza ME, Moses KS. Substance abuse on the college campus. Pediatr Clin North Am. 2005;52(1):307-319.

4. Rome ES. It's a rave new world: rave culture and illicit drug use in the young. Cleve Clin J Med. 2001;68(6):541-550.

5. Kann L, Kinchen S, Shanklin SL, et al. Youth Risk Behavior Surveillance—United States, 2013. MMWR. 2014;63(SS04):1-168.

6. Monitoring the Future. Trends in Annual Prevalence of Use of Various Drugs in Grades 8, 10, and 12. Available at Last accessed November 7, 2018.

7. Monitoring the Future. Marijuana Use is Rising; Ecstasy Use is Beginning to Rise; and Alcohol Use is Declining Among U.S. Teens. Available at Last accessed November 7, 2018.

8. El-Mallakh RS, Abraham HD. MDMA (Ecstasy). Ann Clin Psychiatry. 2007;19(1):45-52.

9. Greene JP, Ahrendt D, Stafford EM. Adolescent abuse of other drugs. Adolesc Med Clin. 2006;17(2):283-318.

10. Substance Abuse and Mental Health Services Administration. The DAWN Report: Ecstasy-Related Emergency Department Visits by Young People Increased Between 2005 and 2011; Alcohol Involvement Remains a Concern. Available at Last accessed November 7, 2018.

11. United Nations Office on Drugs and Crime. World Drug Report 2015. Available at Last accessed November 7, 2018.

12. Morton J. Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol. 2005;5(1):79-86.

13. National Institute on Drug Abuse. MDMA (Ecstasy) Abuse. Available at Last accessed November 7, 2018.

14. National Drug Intelligence Center, Drug Enforcement Administration, United States Customs Service. Joint Assessment of MDMA Trafficking Trends. Johnstown, PA: National Drug Intelligence Center; 2000.

15. Sacco LN, Finklea K. Synthetic Drugs: Overview and Issues for Congress. Available at Last accessed November 7, 2018.

16. Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol. 2015;5(2):97-132.

17. Klein M, Kramer F. Rave drugs: pharmacological considerations. AANA J. 2004;72(1):61-67.

18. Lexicomp Online. Available at Last accessed December 7, 2015.

19. Bang-Ping J. Sexual dysfunction in men who abuse illicit drugs: a preliminary report. J Sex Med. 2009;6(4):1072-1080.

20. Hahn I-H. MDMA Toxicity. Available at Last accessed November 7, 2018.

21. Andresen H, Aydin BE, Mueller A, Iwersen-Bergmann S. An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results. Drug Test Anal. 2011;3(9):560-568.

22. U.S. Drug Enforcement Administration. GHB, GBL and 1,4BD as Date Rape Drugs. Available at Last accessed November 7, 2018.

23. Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate-a drug of abuse. Acta Neurol Scand. 2006;114(3):145-156.

24. Pardi D, Black J. Gamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs. 2006;20(12):993-1018.

25. Benzer TI. Gamma-Hydroxybutyrate Toxicity. Available at Last accessed November 7, 2018.

26. van Noorden MS, Kamal R, de Jong CA, Vergouwen AC, Zitman FG. Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment. Ned Tijdschr Geneeskd. 2010;154:A1286.

27. Kamal RM, Schellekens A, De Jong Ca, Dijkstra BA. Baclofen as relapse prevention in the treatment of Gamma-Hydroxybutyrate (GHB) dependence: an open label study. BMC Psychiatry. 2015;15:91.

28. Li JH, Vicknasingam B, Cheung YW, et al. To use or not to use: an update on licit and illicit ketamine use. Subst Abuse Rehabil. 2011;2:11-20.

29. D'Orazio J. Hallucinogen Toxicity Treatment and Management. Treatment: Prehospital Care. Available at Last accessed November 7, 2018.

30. U.S. Drug Enforcement Administration. DEA Drug Fact Sheet: Rohypnol. Available at Last accessed November 7, 2018.

31. U.S. Drug Enforcement Administration. Drugs of Abuse: Uses and Effects. Available at Last accessed November 7, 2018.

32. Hall JA, Moore CBT. Drug-facilitated sexual assault: a review. J Forensic Leg Med. 2008;15(5):291-297.

33. Basheer C. Recent analytical strategies on "date-rape" drugs and its metabolites. J App Pharm Sci. 2011;1(6):21-28.

34. Brisset C, Leanza Y, Laforest K. Working with interpreters in health care: a systematic review and meta-ethnography of qualitative studies. Patient Educ Couns. 2013;91(2):131-140.

35. Hwa-Froelich DA, Westby CE. Considerations when working with interpreters. Commun Disord Q. 2003;24(2): 78-85.

36. Lynch EW. Developing cross-cultural competence. In: Lynch EW, Hanson MJ (eds). A Guide for Working with Children and Their Families: Developing Cross-Cultural Competence. 3rd ed. Baltimore, MD: Paul H. Brookes Publishing Co.; 2004.

37. Herndon E. Getting the most from language interpreters. Fam Pract Manag. 2004;11(6):37-40.

38. U.S. Drug Enforcement Administration. Gamma Hydroxybutyric Acid. Available at Last accessed November 7, 2018.

39. U.S. Drug Enforcement Administration. 2015 National Drug Threat Assessment (NDTA) Summary. Available at Last accessed November 7, 2018.

40. Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use, 1975–2015: Overview, Key Findings on Adolescent Drug Use. Available at Last accessed November 7, 2018.

41. U.S. Department of Health and Human Services. Trends in the Prevalence of Marijuana, Cocaine, and Other Illegal Drug Use National YRBS: 1991–2017. Available at Last accessed November 7, 2018.

42. Monitoring the Future. National Survey Results on Drug Use: 2017 Overview. Available at Last accessed November 7, 2018.

Evidence-Based Practice Recommendations Citations

1. Clinical Effectiveness Group. UK National Guidelines on the Management of Adult and Adolescent Complainants of Sexual Assault 2011. London: British Association for Sexual Health and HIV; 2012. Available at Last accessed December 3, 2018.

Copyright © 2019 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.